Pfizer's Shanghai R&D Site To Serve As R&D Hub For Asia
This article was originally published in PharmAsia News
Executive Summary
PERTH, Australia - Pfizer's Shanghai R&D site will remain the central R&D hub for Asia, Pfizer Head of Asia R&D Steve Yang told PharmAsia News.